All news

After a dynamic 2nd quarter, Spineway consolidated its growth in Q3 with revenues of €1.1m, an improvement or 22% as compared to Q3 2020, bringing...

Spineway confirmed a sharp 153% 2021 half-year turnover increase compared with 2020 same period despite an international economic context still...

Spineway, specialized in innovative implants for the treatment of severe disorders of the spinal column (spine), informs 2021 half year results are delayed...

In an international context that is still disrupted by the global pandemic, Spineway recorded a 153% increase in revenue for the second quarter of 2021...

This acquisition is part of the Group’s growth strategy and allows Spineway to expand its products and services to provide a wider range of implants and...

Spineway, specialized in innovative implants for the treatment of severe disorders of the spinal column (spine), signed a Memorandum of Understanding for...

Spineway announces that, on 28 April 2021, it filed its Universal Registration Document (“DEU”) for the 2020 financial year with the “Autorité des Marchés...

In accordance with Spineway’s forecasts, revenue for the first quarter of 2021 followed the trend of yearend 2020 and amounted to €0.9M (€1M for Q1...

Spineway, specialized in the design of innovative surgical implants and instruments for the treatment of severe disorders of the spine, continues its...